|
| Title:
|
Novel Interactive Cell phone technology for Health Enhancement (NICHE) |
| Status:
|
Completed |
| Topic:
|
Diabetes / Insulin Resistance |
| Funding Source:
|
Confidant, Inc. through funding by NIH |
| Funding Period:
|
2005-2007 |
| Study Design:
|
Controlled pilot test of feasibility |
| Purpose:
|
To evaluate the feasibility and efficacy of the Palaistra System (interactive cell phone technology) in the management of type 2 diabetes |
| Further Study Details:
|
The Palaistra System is a wireless remote patient monitoring and response system, centered around mobile phone technology, that translates scientifically supported knowledge for chronic disease management into action by providing easily followed daily coaching using the patient’s own data. The controlled trial was designed to evaluate the feasibility and efficacy of the Palaistra System in the management of type 2 diabetes. |
| Findings:
|
The study demonstrated improved levels of glycosylated hemoglobin, positive changes in diabetes management self-efficacy, and diabetes self-care activities among patients in the intervention group who received tailored messages on their cell phones. |
| Eligibility:
|
Patients in two Community Health Centers (Meriden and New Britain, CT) with type 2 diabetes. |